Gastroesphageal reflux disease and coronary heart disease - Coexistence or athological relationship?;Choroba refluksowa przełyku a choroba wieńcowa - Współistnienie czy zależność?

Polski Merkuriusz Lekarski

Volumn 20, Issue 115, 2006, Pages 104-108

  Pulkowski, Grzegorz ^a   Majer, Marcin ^a   Budzyński, Jacek ^a   Świa̧tkowski, Maciej ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Autonomous nervous system; Chest pain; Coronary heart disease; Gastroesophagel reflux disease; Helicobacter pylori

Indexed keywords

CARDIOVASCULAR AGENT;

ANAEROBIC METABOLISM; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; AUTONOMIC NERVOUS SYSTEM; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LOWER ESOPHAGUS SPHINCTER; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PREVALENCE; REFLEX; REVIEW; THORAX PAIN; VAGUS REFLEX; VISCERAL PAIN;

COMORBIDITY; CORONARY DISEASE; GASTROESOPHAGEAL REFLUX; HUMANS; PREVALENCE;

EID: 31944452121     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Achem S.R., Kolts B.E., MacMath T. i wsp.: Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig. Dis. Sci., 1997, 42(10), 2138-45.
2. Are C., Hardacre J.M., Talamini M.A. i wsp.: Decreased cardiac output in humans during laparoscopic antireflux surgery: direct measurements. J. Laparoendosc. Adv. Surg. Tech. A., 2003, 13(3), 139-46.
3. Bortolotti M., Cirignotta F., Labo G. i wsp.: Atrioventricular block induced by swallowing in a patient with diffuse esophageal spasm. JAMA, 1982, 248(18), 2297-9.
4. Bortolotti M., Sarti P., Brunelli F. i wsp.: Abnormal esophagocardiac inhibitory reflex in patients with diffuse esophageal spasm. Digestion, 1995, 56(6), 488-92.
5. Botoman V.A.: Noncardiac chest pain. J. Clin. Gastroenterol., 2002, 34(1), 6-14.
6. Braunwald: Hart Disease. 1998 by W. B. Saunders Company Copyright, 1994, Folio Corporation, Part III, Chapter 38.
7. Budzynski J. i wsp.: Kwaśny refluks żoła̧dkowo- przełykowy może być klinicznie istotnym czynnikiem wpływaja̧jcym na "gotowość skurczowa̧ " naczyń wieńcowych. Kardiologia Polska, 1999, 51(suppl.II), 55.
8. Budzynski J., Klopocka M., Bujak R. i wsp.: Autonomic nervous function in Helicobacter pylori infected patients with atypical chest pain studied by analysis of heart rate variability. Eur. J. Gastroenterol. Hepatol., 2004, 16(5), 451-7.
9. Budzynski J., Klopocka M., Swiatkowski M. i wsp.: Wpływ zakażenia Helicobacter pylori na wielkość refluksu żoła̧dkowo-przełykowego u pacjentów diagnozowanych z powodu nietypowych bólów w klatce piersiowej. Pol. Arch. Med. Wewn., 2004, 111(2), 143-51.
10. Budzyński J., Kłopocka M., Świa̧tkowski M.: Choroba refleksowa przełyku jako ważny element diagnostyki różnicowej bólu w klatce piersiowej. Pol. Arch. Med. Wewn., 1999, 102(3), 807-14.
11. Budzynski J., Swiatkowski M., Kłopocka M. i wsp.: Zależność wyników elektrokardiograficznej próby wysiłkowej od pH wewna̧trzprzełykowego u mȩżczyzn z nietypowymi bólami w klatce piersiowej. Pol. Arch. Med. Wew., 2000, 103(3-4), 133-8.
12. Caldwell M.T., Byrne P.J., Marks P. i wsp.: Bradykinin, coronary artery disease and gastro-oesophageal reflux. Br. J. Surg., 1994, 81(10), 1462-4.
13. Chambers J., Cooke R., Anggiansah A. i wsp.: Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience. Int. J. Cardiol., 1998, 65(1), 51-5.
14. Chauhan A., Mullins P.A., Taylor G. i wsp.: Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J. Am. Coll. Cardiol., 1996, 27(7), 1621-8.
15. Chen C.L., Orr W.C.: Autonomic responses to heartburn induced by esophageal acid infusion. J. Gastroenterol. Hepatol., 2004, 19(8), 922-6.
16. Conway D.S., Lip G.Y.: Helicobacter pylori as the cause of coronary artery restenosis following angioplasty is the way to a man's heart disease through his stomach? Dig. Liver Dis., 2001, 33(3), 214-6.
17. Cunningham E.T. Jr, Ravich W.J., Jones B. i wsp.: Vagal reflexes referred from the upper aerodigestive tract: an infrequently recognized cause of common cardiorespiratory responses. Ann. Int. Med., 1992, 116(7), 575-82.
18. Davies H.A., Page Z., Rush E.M., i wsp.: Oesophageal stimulation lowers exertinal angina threshold. Lancet, 1985, 1(8436), 1011-4.
19. Dierkes J., Ebert M., Malfertheiner P. i wsp.: Helicobacter pylori infection, vitamin B12 and homocysteine. A revew. Dig. Dis., 2003, 21(3), 237-44.
20. Dobrzycki S., Baniukiewicz A., Musial W.J., i wsp.: Choroba niedokrwienna serca a choroba refluksowa przełyk ocena za pomoca̧ jednoczasowego 24 godzinnego monitorowania EKG i pH w przełyku. Przegl. Lek., 2002, 59(9), 675-7.
21. Fontan J.P., Heldt G.P., Heyman M.B. J.P. i wsp.: Esophageal spasm associated with apnea and bradycardia in an infant. Pediatrics, 1984, 73(1), 52-5.
22. Giec L.: Choroba niedokrwienna serca. PZWL, 1996, 143.
23. Howarth D., Oldfield G., Booker J., i wsp.: Esophageal dysfunction in patients with atypical chest pain investigated with esophageal scintigraphy and myocardial perfusion imaging: an outcome study. J. Nucl. Cardiol., 2003, 10(5), 490-7.
24. Janssens J.P., Vantrappen G.: Irritable esophagus. Am. J. Med., 1992, 92 (suppl.5A) 27-32.
25. Januszewicz W., Kokot F.: Interna. PZWL, 2004, tom I, 137.
26. Januszewicz W., Kokot F.: Interna, PZWL 2004, tom I, 135-136.
27. Kern M., Hofmann C., Hyde J. i wsp.: Characterization of the cerebral cortical representation of heartburn in GERD patients. Am. J. Physiol. Gastrointest Liver, Physiol., 2004, 286(1), G174-81.
28. Kłopocka M., Budzyński J., Świa̧tkowski M i wsp.: Autonomic nervous System activity estimated by heart rate variability analysis in patients with atypical chest pain. Gastroenterol. Pol., 2004, 11(6), 529-534.
29. Kowalski M., Konturek P.C., Pieniazek P. i wsp.: Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig. Liver Dis., 2001, 33(3), 222-229.
30. Kowalski M., Rees W., Konturek P.C. i wsp.: Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig. Liver Dis., 2002, 34(6), 398-402.
31. Loffeld R.J., van der Hulst R.W.: Helicobacter pylori and gastro-oesophageal reflux disease: association and clinical implications. To treat or not to treat with anti-H. pylori therapy? Skand. J. Gastroenterol., 2002 (Suppl), (236), 15-8.
32. Mellow M.H., Simpson A.G., Watt L., i wsp.: Esophageal acid perfusion in coronary artery disease. Induction of myocardial ischemia. Gastroenterology, 1983, 85(2), 306-12.
33. Naruszewicz M.: Czy homocysteina istotnie zwiȩksza ryzyko choroby niedokrwiennej serca? Czynniki Ryzyka, 1997, 17/18, 8-10.
34. Patai A., Sipos E., Dobronte Z.: Sinoatrial block caused by gastroesophageal reflux. The role of simultaneous 24 hr. esophageal pH-metry and Holter-ECG in the differential diagnosis of angina pectoris. Orv. Hetil., 1996, 137(13), 687-90.
35. Pirtniecks A., Smith L.F., Thorpe J.A. i wsp.: Autonomic dysfunction in non-specific disorders of oesophageal motility. Eur. J. Cardiothorac Surg., 2000, 17(2), 101-5.
36. Schofield P.M., Whorwell P.J., Brooks N.H., i wsp.: Oesophageal function in patients with angina pectoris: a comparison of patients with normal coronary angiograms and patients with coronary artery disease. Digestion, 1989, 42(2), 70-8.
37. Singh S., Richter J.E., Hewson E.G. i wsp.: The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann. Int. Med., 1992, 117(10), 824-830.
38. Stone A.F., Mendall M.A., Kaski J.C. i wsp.: Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation, 2002, 106(10), 1219-23.
39. Svensson O., Stenport G., Tibbling L., i wsp.: Oesophageal function and coronary angiogram in patients with disabling chest pain. Acta. Med. Scand., 1978, 204(3), 173-8.
40. Świa̧tkowski M. i wsp.: Gastroenterologiczne przyczyny dolegliwości kardiologicznych. Kardiol. Pol., 2002, 57(9), 261-267.
41. Świa̧tkowski M., Budzynski J., Klopocka M. i wsp.: Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease. Med. Sci. Monit., 2004, 10(9), CR524-529.
42. Traczyk W. Z., Trzebski A.: Fizjologia człowieka z elementami fizjologii stosowanej i klinicznej. PZWL, 1990, tom 2, 274-277.
43. Traczyk W. Z., Trzebski A.: Fizjologia człowieka z elementami fizjologii stosowanej i klinicznej. PZWL, 1990, tom 1, 370.
44. Weigl M., Gschwantler M., Gatterer E. i wsp.: Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med. J., 2003, 96(11), 1128-32.
45. Xia H.H., Lai K.C., Lam S.K. i wsp.: Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment. Pharmacol. Ther., 2003, 17(3), 369-77.